KalVista Pharmaceuticals, Inc. (LSX:A2DG49) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Nov 21, 2016 – Oct 12, 2017 · Past |
| Arnold L Oronsky Other companies: PMV Pharmaceuticals, Inc. (Director · Sep 24, 2020 – Sep 25, 2020 · Past); MacroGenics, Inc. (Director · Oct 9, 2013 – Feb 18, 2014 · Past); Tesaro Inc (Director · Jun 27, 2012 – Aug 7, 2018 · Past); Anesiva Inc (Director · Jun 22, 2006 – May 9, 2008 · Past); Myogen Inc (Director · May 4, 2006 – Nov 13, 2006 · Past); Dynavax Technologies Corporation (Director · Feb 23, 2006 – May 28, 2020 · Past) | Director · Nov 21, 2016 – Oct 1, 2020 · Past |
| William C. Fairey Other companies: Ascendis Pharma A/S (Director · Since at least Mar 18, 2026); Rein Therapeutics, Inc. (Director · Since at least Oct 31, 2023); Mirum Pharmaceuticals, Inc. (Director · Since at least Aug 19, 2021); MyoKardia Inc (EVP, Chief Commercial Officer · Jan 28, 2019 – Nov 17, 2020 · Past); ChemoCentryx Inc. (Chief Operating Officer · Jan 3, 2018 – Jan 3, 2018 · Past) | Director · Since at least Apr 18, 2024 |
| Albert Cha Other companies: Ascendis Pharma A/S (Chairman · Since at least Mar 18, 2026); Biohaven Pharmaceutical Holding Co Ltd (Director · May 3, 2017 – May 1, 2018 · Past); Aclaris Therapeutics, Inc. (Director · Oct 6, 2015 – Jun 29, 2016 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jul 21, 2015 · Past) | Director · Mar 23, 2017 – Sep 26, 2023 · Past |
| Richard Aldrich Other companies: Concert Pharmaceuticals Inc (Director · Feb 12, 2014 – Mar 6, 2023 · Past); PTC Therapeutics, Inc. (Director · Mar 7, 2013 – Jun 8, 2015 · Past); Tempest Therapeutics, Inc. (Director · Jun 11, 2012 – Dec 7, 2018 · Past); Verastem, Inc. (Director · Jan 26, 2012 – Jun 10, 2014 · Past) | Director · Nov 21, 2016 – Oct 3, 2018 · Past |
| Brian Piekos Other companies: Elicio Therapeutics, Inc. (Chief Financial Officer · Jun 1, 2023 – Feb 1, 2024 · Past); Disc Medicine, Inc. (CFO · Feb 12, 2021 – May 31, 2022 · Past); AMAG Pharmaceuticals Inc (Chief Financial Officer · Jun 9, 2020 – Nov 16, 2020 · Past) | Chief Financial Officer · Since at least Sep 9, 2024 |
| Bilal Arif Other companies: Sarepta Therapeutics, Inc. (Chief Tech Ops Officer · Since at least Dec 31, 2022) | Chief Operating Officer · Since at least Oct 6, 2025 |
| Brian J. G. Pereira Other companies: ProKidney Corp. (Director · Since at least May 30, 2024) | Director · Since at least Oct 3, 2024 |
| Nancy Stuart Other companies: Concert Pharmaceuticals Inc (Chief Operating Officer · Jan 6, 2023 – Mar 6, 2023 · Past) | Director · Since at least Oct 13, 2022 |
| Nicole Sweeny Other companies: Monopar Therapeutics Inc. (Board Member · Since at least Jun 22, 2026) | Chief Commercial Officer · Since at least Jun 18, 2025 |
| Andreas Maetzel | Senior Vice President, Medical · Mar 7, 2017 – May 26, 2021 · Past |
| Benjamin L Palleiko | CHIEF EXECUTIVE OFFICER, Director · Since at least Apr 16, 2026 |
| Bethany L. Sensenig | Director · Since at least Oct 2, 2025 |
| Christopher Yea | CHIEF DEVELOPMENT OFFICER · Since at least May 17, 2025 |
| Edward W Unkart | Director · Since at least Mar 23, 2017 |
| Jeb Ledell | Chief Operating Officer · Since at least Dec 16, 2024 |
| Jenn Snyder | Vice President, Corporate Affairs · Since at least Feb 10, 2025 |
| Laurence Reid | Director · Since at least Nov 26, 2024 |
| Leah Monteiro | Senior Director, Corporate Communications & Investor Relations · Since at least Feb 3, 2026 |
| Michael David Smith | Senior VP, Development · Dec 16, 2020 – May 17, 2022 · Past |
| Molly Cameron | Sr. Director, Corporate Communications · Since at least Apr 8, 2026 |
| Paul K Audhya | CHIEF MEDICAL OFFICER · Since at least May 17, 2025 |
| Ryan Baker | Head, Investor Relations · Since at least Apr 29, 2026 |
| Thomas Andrew Crockett | CEO, Director · Jun 4, 2018 – Feb 17, 2024 · Past |